PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan.\', \'Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 106, Taiwan; Genomics Research Center, Academia Sinica, Taipei, 115, Taiwan.\', \'Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 106, Taiwan.\', \'Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 106, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 106, Taiwan. Electronic address: sychang@ntu.edu.tw.\', \'Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan; Center of Biotechnology, National Taiwan University, Taipei, 106, Taiwan. Electronic address: shihchung@ntu.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(22)00058-410.1016/j.antiviral.2022.105290
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 35296418
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all